Article Versions Notes

Tarbiah NI, Alkhattabi NA, Alsahafi AJ, Aljahdali HS, Joharjy HM, Al-Zahrani MH, Sabban AM, Alghamdi RA, Balgoon MJ, Khalifa RA. T Cells Immunophenotyping and CD38 Overexpression as Hallmarks of the Severity of COVID-19 and Predictors of Patients’ Outcomes. Journal of Clinical Medicine. 2023; 12(2):710. https://doi.org/10.3390/jcm12020710

Tarbiah, Nesrin I., Nuha A. Alkhattabi, Abdullah J. Alsahafi, Hani S. Aljahdali, Husam M. Joharjy, Maryam H. Al-Zahrani, Aliaa M. Sabban, Rana A. Alghamdi, Maha J. Balgoon, and Reham A. Khalifa. 2023. "T Cells Immunophenotyping and CD38 Overexpression as Hallmarks of the Severity of COVID-19 and Predictors of Patients’ Outcomes" Journal of Clinical Medicine 12, no. 2: 710. https://doi.org/10.3390/jcm12020710

Tarbiah, N. I., Alkhattabi, N. A., Alsahafi, A. J., Aljahdali, H. S., Joharjy, H. M., Al-Zahrani, M. H., Sabban, A. M., Alghamdi, R. A., Balgoon, M. J., & Khalifa, R. A. (2023). T Cells Immunophenotyping and CD38 Overexpression as Hallmarks of the Severity of COVID-19 and Predictors of Patients’ Outcomes. Journal of Clinical Medicine, 12(2), 710. https://doi.org/10.3390/jcm12020710